SB 427

  • California Senate Bill
  • 2023-2024 Regular Session
  • Introduced in Senate Feb 13, 2023
  • Passed Senate May 24, 2023
  • Passed Assembly Apr 11, 2024
  • Governor

Health care coverage: antiretroviral drugs, drug devices, and drug products.

Abstract

Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally prohibits a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs that are medically necessary for the prevention of HIV/AIDS, including preexposure prophylaxis or postexposure prophylaxis, to prior authorization or step therapy. Under existing law, a health care service plan or health insurer is not required to cover all the therapeutically equivalent versions of those drugs without prior authorization or step therapy if at least one is covered without prior authorization or step therapy. This bill would prohibit a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs, drug devices, or drug products that are either approved by the United States Food and Drug Administration (FDA) or recommended by the federal Centers for Disease Control and Prevention (CDC) for the prevention of HIV/AIDS, to prior authorization or step therapy, but would authorize prior authorization or step therapy if at least one therapeutically equivalent version is covered without prior authorization or step therapy and the plan or insurer provides coverage for a noncovered therapeutic equivalent antiretroviral drug, drug device, or drug product without cost sharing pursuant to an exception request. The bill would require a plan or insurer to provide coverage under the outpatient prescription drug benefit for those drugs, drug devices, or drug products, including by supplying participating providers directly with a drug, drug device, or drug product, as specified. This bill would require a nongrandfathered or grandfathered health care service plan contract or health insurance policy to provide coverage for antiretroviral drugs, drug devices, or drug products that are either approved by the FDA or recommended by the CDC for the prevention of HIV/AIDS, and would prohibit a nongrandfathered or grandfathered health care service plan contract or health insurance policy from imposing any cost-sharing or utilization review requirements for those drugs, drug devices, or drug products. The bill would exempt Medi-Cal managed care plans from these provisions and would delay the application of these provisions for an individual and small group health care service plan contract or health insurance policy until January 1, 2026. Because a willful violation of these provisions by a health care service plan would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Bill Sponsors (1)

Votes


Actions


May 13, 2024

Assembly

In Assembly. Held at Desk.

Senate

Ordered to the Assembly.

Apr 11, 2024

Senate

In Senate. Concurrence in Assembly amendments pending.

Assembly

Read third time. Passed. (Ayes 62. Noes 0. Page 4746.) Ordered to the Senate.

Apr 04, 2024

Assembly

Read third time and amended.

Assembly

Ordered to third reading.

Feb 26, 2024

Assembly

Ordered to third reading.

Assembly

From inactive file.

Feb 22, 2024

Assembly

Notice of intention to remove from inactive file given by Assembly Member Zbur.

Sep 14, 2023

Assembly

Ordered to inactive file on request of Assembly Member Zbur.

Sep 08, 2023

Assembly

Ordered to third reading.

Assembly

Read third time and amended.

Sep 05, 2023

Assembly

Read second time. Ordered to third reading.

Sep 01, 2023

Assembly

From committee: Do pass. (Ayes 13. Noes 1.) (September 1).

Aug 23, 2023

Assembly

August 23 set for first hearing. Placed on suspense file.

Aug 14, 2023

Assembly

Read second time and amended. Re-referred to Com. on APPR.

  • Amendment-Passage
  • Reading-1
  • Reading-2
  • Referral-Committee
Com. on APPR.

Jul 14, 2023

Assembly

From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 12. Noes 0.) (July 11).

Jun 13, 2023

Assembly

From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.

  • Amendment-Passage
  • Committee-Passage
  • Reading-1
  • Reading-2
  • Referral-Committee
Com. on HEALTH.

Jun 01, 2023

Assembly

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

May 25, 2023

Assembly

In Assembly. Read first time. Held at Desk.

May 24, 2023

Senate

Read third time. Passed. (Ayes 33. Noes 1. Page 1276.) Ordered to the Assembly.

May 18, 2023

Senate

From committee: Do pass. (Ayes 5. Noes 1. Page 1170.) (May 18).

Senate

Read second time. Ordered to third reading.

May 12, 2023

Senate

Set for hearing May 18.

May 08, 2023

Senate

May 8 hearing: Placed on APPR suspense file.

May 01, 2023

Senate

Set for hearing May 8.

Apr 27, 2023

Senate

From committee: Do pass and re-refer to Com. on APPR. (Ayes 10. Noes 0. Page 940.) (April 26). Re-referred to Com. on APPR.

  • Committee-Passage
  • Committee-Passage-Favorable
  • Referral-Committee
Com. on APPR.

Apr 12, 2023

Senate

Set for hearing April 26.

Mar 29, 2023

Senate

Re-referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

Mar 21, 2023

Senate

From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS.

  • Amendment-Passage
  • Committee-Passage
  • Reading-1
  • Reading-2
  • Referral-Committee
Com. on RLS.

Feb 22, 2023

Senate

Referred to Com. on RLS.

  • Referral-Committee
Com. on RLS.

Feb 14, 2023

Senate

From printer. May be acted upon on or after March 16.

Feb 13, 2023

Senate

Introduced. Read first time. To Com. on RLS. for assignment. To print.

Bill Text

Bill Text Versions Format
SB427 HTML
02/13/23 - Introduced PDF
03/21/23 - Amended Senate PDF
06/13/23 - Amended Assembly PDF
08/14/23 - Amended Assembly PDF
09/08/23 - Amended Assembly PDF
04/04/24 - Amended Assembly PDF

Related Documents

Document Format
04/24/23- Senate Health PDF
05/05/23- Senate Appropriations PDF
05/20/23- Sen. Floor Analyses PDF
07/07/23- Assembly Health PDF
08/21/23- Assembly Appropriations PDF
09/05/23- ASSEMBLY FLOOR ANALYSIS PDF
09/08/23- ASSEMBLY FLOOR ANALYSIS PDF
04/04/24- ASSEMBLY FLOOR ANALYSIS PDF
04/12/24- Sen. Floor Analyses PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.